Tag: orphan diseases

STUDY REVEALS SIGNIFICANT GLOBAL VARIATION IN THE DEFINITION OF THE TERM “RARE DISEASE”

First International Study of Its Kind Published in ISPOR’s Value in Health  Princeton, NJ—October 26, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published results of an expansive global review answering a basic scientific question, “How do you describe

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , ,

WHAT`S GOING ON WITH THE TURKISH ORPHAN DRUGS MARKET?

Ankara, Turkey – Many countries and regions have already defined health policies on orphan drugs for rare diseases. Although there is no official definition in Turkey, all orphan drugs are covered by reimbursement, regardless of their market authorization status.

Posted in Announcements, Health Policy Analyses, Value in Health Regional Issues Tagged with: , , , , , , , ,